D-0178-2026 Class II Ongoing

Recalled by Park Avenue Compounding — Saint Louis, MO

FDA drug recall D-0178-2026 was initiated by Park Avenue Compounding on Sep 23, 2025 and is designated Class II. Reason for recall: CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results. The recall status is ongoing. Affected quantity: 189 bags.

Recall details

Product Type
Drugs
Report Date
Nov 26, 2025
Initiation Date
Sep 23, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
189 bags

Product description

Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1.

Reason for recall

CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

Distribution pattern

Distributed in Missouri

Code information

Lot # 20250507-01D93C, Exp Date: 11-04-2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0178-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0178-2026. Report a data issue: hello@regdatalab.com.